This inventor holds 2 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., The General Hospital Corporation. Active years: 2016-2018.
Company Filing History:
2 out of 8,568 
2 out of 480 
2 out of 3,067 
Years Active: 2016-2018
Title: The Innovator Behind Cancer-Related Extracellular Matrix Signatures: Karl Clauser
Introduction
Karl Clauser, a notable inventor based in Boston, MA, has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents to his name, Clauser focuses on the identification of cancer-related proteins and their applications in diagnosis and treatment.
Latest Patents
Clauser's latest patents address cancer-related extracellular matrix signatures and related methods and products. These patents provide proteomic methods for identifying cancer-specific proteins associated with various aspects of cancer. They include panels or signature sets of proteins that are useful in the detection, diagnosis, and treatment of cancers, as well as in monitoring therapeutic progress in cancer patients. The proteins identified in his research, particularly beneficial for colon cancer patients, were uncovered through proteomics analyses of tissue samples taken from individuals diagnosed with cancer. The methods outlined in these patents also facilitate targeting imaging and therapeutic agents to tumors by binding to the specified proteins.
Career Highlights
Throughout his career, Clauser has worked with prestigious institutions that have bolstered his research endeavors. He has been affiliated with the Massachusetts Institute of Technology and The General Hospital Corporation, where he has likely collaborated with leading experts in the field.
Collaborations
Clauser's work has been enriched through collaborations with notable scientists such as Richard O Hynes and Alexandra Naba. These partnerships have contributed to advancing the understanding of cancer biology and improving approaches to diagnosis and treatment.
Conclusion
Karl Clauser is an exemplary inventor whose work significantly impacts the medical field, particularly in oncology. His innovative approaches to identifying cancer-related proteins hold promise for enhancing early detection and treatment strategies, paving the way for better patient outcomes in cancer care.